Exploring targeted pulmonary delivery for treatment of lung cancer
1★, 1, 1, 1★ Corresponding author
- 1Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard University, New Delhi, INDIA.
CORRESPONDENCE
Amit Goel
Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard University, New Delhi, INDIA.
Volume 3, Issue 1 · pp. 8-14 · 2013 · DOI: 10.4103/2230-973X.108959
ABSTRACT
Lung cancer is the most malignant cancer today. The treatment of lung cancer continues to be a challenge for oncologists. The direct delivery of chemotherapeutic agents to the lungs could represent a novel therapeutic approach for patients with pulmonary metastases. The large alveolar surface area, the low thickness of the epithelial barrier, and an extensive vascularization make the pulmonary route an ideal route for administration of oncolytics. This paper reviews the research performed over the last and current decades on the delivery of various oncolytics for pulmonary delivery for the treatment of lung cancer. Inhaled drug delivery devices in cancer therapy are also discussed in the present manuscript.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Goel, A., Baboota, S., Sahni, J. K., & Ali, J. (2013). Exploring targeted pulmonary delivery for treatment of lung cancer. International Journal of Pharmaceutical Investigation, 3(1), 8-14. https://doi.org/10.4103/2230-973X.108959
Copyright and licence
© 2013 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0